Scientists at the 2026 ACTRIMS forum meet to assess current approaches and explore new directions for MS research and care.

Advancements in MS include promising therapies like BTK inhibitors and myelin repair, evolving biomarkers, and a focus on cognition, signaling a promising future in precision medicine.

The earliest symptoms of multiple sclerosis (MS) can come and go, which makes them easy to ignore — and makes diagnosing this common neurological disease complicated. That’s why it’s so important to ...

Radiologically isolated syndrome (RIS) is a condition in which a person’s MRI brain scan shows abnormalities and lesions like those seen in multiple sclerosis (MS), but they haven’t experienced any MS ...

A prospective cohort study, using data from the UK Biobank, suggested that the Mediterranean diet could provide benefits to patients with multiple sclerosis. The Mediterranean diet involves consuming ...

A generation ago, most people with multiple sclerosis could expect to rely on walkers and wheelchairs or be limited to their bed within 15 years of diagnosis. Today, UC San Francisco’s discoveries are ...

For decades, multiple sclerosis (MS) has been defined primarily by its symptoms, rather than its underlying biology. Now, a ...

The results reinforce the need for individualized, biology-driven therapeutic decisions in patients with MS. SAN DIEGO – ...

Multiple sclerosis (MS) is a chronic autoimmune disorder of the central nervous system, including the brain, spinal cord, and optic nerves. The body mistakenly attacks and damages the protective ...